OUR MISSION
Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the greatest morbidity and mortality. We are developing oral brepocitinib, a potential first-in-class dual inhibitor of TYK2 and JAK1, across multiple severe autoimmune indications, unlocking new treatment options for patients who are underserved by existing therapies.
OUR TEAM
Matt Ackermann
Senior Director & Head, Global Medical Affairs
Ade Adeboye
Director, Clinical Development
Shauna Anderson
Associate Director, Quality
Rory Bales
Senior Manager, Regulatory Affairs
Kelly Barghausen
Director, Regulatory Affairs
Eric Bashkoff
Senior Software Engineer
Courtney Cupples
Chief Commercial Officer
Lisa Dyer
Senior Manager, Clinical Operations
Derek Gonzalez
Clinical Research Associate
Sasha Goriounova
Early Development Fellow
Heather Greene
Associate Director, Statistical Programming
Austin Gromatzky
SVP, Strategy and Business Development
Ruth Hager
Director, Pharmacovigilance
Dan Hazen
Controller
Daniel Herz-Roiphe
Chief Operating Officer
Whitney Holmes
Executive Assistant to the CEO & Team Coordinator
Megan Huey
Head of People
Noriko Iikuni
VP, Clinical Development
Nasif Islam
Director, Strategy and Business Development
Brendan Johnson
SVP, Early Development
Scott Jones
Director, Clinical Operations
Brian Junio
Senior Clinical Research Associate
George Kokkines
General Counsel
Beth Lang
SVP, Regulatory Affairs & Pharmacovigilance
Debbie Lee
Associate Director, Accounting
Rob Livingston
VP, CMC
Ryan Mann
Associate, Clinical Operations
Tyler Massaro
Principal Biostatistician
Lisa McConnachie
Associate Director, Nonclinical Development
Scott Mitchell
Senior Director, Analytical Development
Paul Mudd
Chief Development Officer
Karen Onwu
Senior Clinical Research Associate
Sergey Pavlenko
Director, Clinical Operations
Sabrina Pogrebivsky
Manager, Clinical Operations
Alissa Respet
Associate Director, Quality Systems
Lindsey Rios
SVP, Program Management & Clinical Operations
Chiara Salvati
Rotational Analyst
Denise Shortino
VP, Biometrics
Taryn Smith
Patient Evaluation Manager
Tracy Smith
Associate Director, Data Management
Bruce Stevens
SVP, Quality
Christin Thompson
Senior Clinical Research Associate
David Tromblay
Senior Associate, Quality
Alysa Vereen
Senior Manager, Regulatory Affairs
Drew Webster
Director, Operations
Flora Wong
Associate Director, Supply Chain
Frank Zhang
Senior Director, Drug Product Development & Manufacturing
Ben Zimmer
Chief Executive Officer
Ben Zimmer
Chief Executive Officer
Paul Mudd
Chief Development Officer
Courtney Cupples
Chief Commercial Officer
Daniel Herz-Roiphe
Chief Operating Officer
Austin Gromatzky
SVP, Strategy and Business Development
Frank Torti
Executive Chairman
Irena Melnikova
Director
Eric Venker
Director